Community Medicine (PSM) · National Health Programmes (NTEP, NVBDCP, NACP, NIS, RMNCH+A)

Under NVBDCP, what is the recommended single-dose treatment for kala-azar (visceral leishmaniasis) in India?

  • A Sodium stibogluconate 20 mg/kg for 30 days
  • B Miltefosine 50 mg for 28 days
  • C Liposomal amphotericin B 10 mg/kg single infusion
  • D Paromomycin 11 mg/kg for 21 days
Correct answer: C. Liposomal amphotericin B 10 mg/kg single infusion

Explanation

NVBDCP recommends liposomal amphotericin C 10 mg/kg as a single intravenous infusion for kala-azar in India. This is part of the Kala-Azar Elimination Programme targeting elimination (less than 1 case per 10,000 population at block level). Sodium stibogluconate is the older, more toxic alternative.

Reference: Park's Textbook of Preventive and Social Medicine, 27th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 43,000+ MCQs.

Start free → Log in

More National Health Programmes (NTEP, NVBDCP, NACP, NIS, RMNCH+A) MCQs

See all National Health Programmes (NTEP, NVBDCP, NACP, NIS, RMNCH+A) MCQs →